"Chimerism" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from different individuals. This contrasts with MOSAICISM in which the different cell populations are derived from a single individual.
| Descriptor ID |
D046528
|
| MeSH Number(s) |
G05.365.590.175.125
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Chimerism".
Below are MeSH descriptors whose meaning is more specific than "Chimerism".
This graph shows the total number of publications written about "Chimerism" by people in this website by year, and whether "Chimerism" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2009 | 0 | 2 | 2 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2015 | 0 | 1 | 1 |
| 2018 | 0 | 2 | 2 |
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chimerism" by people in Profiles.
-
Mixed donor chimerism following stem cell transplantation for sickle cell disease. Curr Opin Hematol. 2023 11 01; 30(6):187-193.
-
Post-transplant CD34+ selected stem cell boost as an intervention for declining mixed chimerism following reduced intensity conditioning allogeneic stem cell transplant in children and young adults with sickle cell disease: A case series. Pediatr Hematol Oncol. 2022 08; 39(5):475-480.
-
Performance characteristics of chimerism testing by next generation sequencing. Hum Immunol. 2022 Jan; 83(1):61-69.
-
Donor-Host Lineage-Specific Chimerism Monitoring and Analysis in Pediatric Patients Following Allogeneic Stem Cell Transplantation: Influence of Pretransplantation Variables and Correlation with Post-Transplantation Outcomes. Transplant Cell Ther. 2021 09; 27(9):780.e1-780.e14.
-
Busulfan-based reduced toxicity conditioning regimen used in hematopoietic stem cell transplantation in HLH patients results in sustained donor chimerism. Pediatr Hematol Oncol. 2021 05; 38(4):410-416.
-
Post-transplantation cyclophosphamide for chimerism-based tolerance. Bone Marrow Transplant. 2019 08; 54(Suppl 2):769-774.
-
High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease. Biol Blood Marrow Transplant. 2018 08; 24(8):1643-1650.
-
Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide Using Non-First-Degree Related Donors. Biol Blood Marrow Transplant. 2018 05; 24(5):1099-1102.
-
A 15-year-old boy with severe combined immunodeficiency, fungal infection, and weight gain. Allergy Asthma Proc. 2015 Sep-Oct; 36(5):407-11.
-
Increasing chimerism after allogeneic stem cell transplantation is associated with longer survival time. Biol Blood Marrow Transplant. 2014 Aug; 20(8):1139-44.